Sec. 30. (a) Sections 16 and 20 of this chapter do not apply to the actions of a:
(1) person who is employed or retained as an investigator by a pharmaceutical manufacturer described in subdivision (3);
(2) practitioner; or
(3) pharmaceutical manufacturer that is approved by the federal Food and Drug Administration;
performed in an investigation of a pharmaceutical manufacturer's legend drug that is suspected of being counterfeited, adulterated, or misbranded.
(b) A drug sample collected during an investigation described in subsection (a) may only be used for testing or a civil or criminal action. A drug sample collected during an investigation may not be resold or provided for human consumption.
(c) A pharmaceutical manufacturer that collects drug samples during an investigation described in subsection (a) shall:
(1) maintain records of the drug samples; and
(2) make these records available, at a reasonable time, to law enforcement agencies or the agencies' representatives in the enforcement of this chapter.
As added by P.L.48-2015, SEC.4.
Structure Indiana Code
Article 42. Regulation of Food, Drugs, and Cosmetics
Chapter 19. Drugs: Indiana Legend Drug Act
16-42-19-4. "Investigational or New Drug"
16-42-19-11. Sale of Legend Drug Unlawful; Conditions; Exceptions
16-42-19-12. Refilling Prescription or Drug Order
16-42-19-13. Possession or Use of Legend Drug or Precursor
16-42-19-15. Inspection of Records
16-42-19-17. Legend Drug Smoking Devices
16-42-19-18. Legend Drug Injection Devices; Violation
16-42-19-19. Anabolic Steroids
16-42-19-20. Validity of Prescriptions or Drug Orders
16-42-19-21. Authorized Sale or Possession
16-42-19-22. Manufacturers and Wholesalers; Records
16-42-19-25. Anabolic Steroids; Unlawful Acts
16-42-19-27. Violations; Prior Offenders; Anabolic Steroids
16-42-19-28. Immunity of Law Enforcement Officers From Prosecution
16-42-19-30. Investigation of Suspected Legend Drugs; Records